Closing the Gap in HPP Care Global medical education programme in hypophosphatasia (HPP) This medical education programme is organised and funded by Alexion, AstraZeneca Rare Disease and is intended for healthcare professionals only.
advance I am a healthcare professional

 I am not a
healthcare professional

Expect concise plenary talks, real-world case studies, interactive discussions and panel Q&A sessions. 


This year's programme is designed to enhance understanding of the diagnostic challenges of hypophosphatasia (HPP) and the real-life impact the condition has on patients, drawing on practical insights shared by healthcare professionals worldwide.

Two important topics will be covered in this year's programme on two dates.

To accommodate a global audience, two sessions are available on each day.

Choose the sessions that are more suitable for you:

Rethinking HPP Diagnosis:
Approaches and Clinical Insights

Tuesday, 2 December

Session 1

02:30–04:00 Pacific | 05:30–07:00 Eastern | 10:30–12:00 UK | 11:30–13:00 CET | 18:30–20:00 China | 19:30–21:00 Japan

Session 2

09:00–10:30 Pacific | 12:00–13:30 Eastern | 17:00–18:30 UK | 18:00–19:30 CET | 01:00–02:30 (+1) China | 02:00–03:00 (+1) Japan

Living with HPP:
Rethinking the Disease Burden

Tuesday, 4 December

Session 1

02:30–04:00 Pacific | 05:30–07:00 Eastern | 10:30–12:00 UK | 11:30–13:00 CET | 18:30–20:00 China | 19:30–21:00 Japan

Session 2

09:00–10:30 Pacific | 12:00–13:30 Eastern | 17:00–18:30 UK | 18:00–19:30 CET | 01:00–02:30 (+1) China | 02:00–03:00 (+1) Japan

REGISTER FOR THE WEBINARS HERE
This medical education programme is organised and funded by Alexion, AstraZeneca Rare Disease and is intended for healthcare professionals only. M/GL/Med HPP/0066 | October 2025